Savage Brian 4
4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Mar 9, 2026
Research Summary
AI-generated summary of this filing
TEVA Interim CLO Brian Savage Exercises RSUs, Sells 1,127 Shares
What Happened
Brian Savage, TEVA’s Interim Chief Legal Officer, had 3,580 restricted share units (RSUs) vest on March 5, 2026 and these converted to 3,580 ordinary shares (reported as an exercise/conversion). On the same date he disposed of 1,127 shares in an open‑market sale for a weighted average price of $31.67, generating $35,690 in proceeds. The filing also shows 3,580 shares were marked as disposed with $0 proceeds — these represent shares withheld/settled to satisfy tax withholding associated with the RSU vesting.
Key Details
- Transaction date: March 5, 2026; Form 4 filed March 9, 2026 (timely).
- Open‑market sale: 1,127 shares at a weighted average price of $31.67; proceeds $35,690. Price range across trades: $31.26–$32.34 (footnote F4).
- RSU conversion (exercise/conversion, code M): 3,580 shares acquired upon vesting; 3,580 shares shown as disposed at $0, reflecting tax withholding/net settlement (footnote F3).
- RSU grant/vesting schedule: RSUs were granted Mar 5, 2025; 3,580 vested on Mar 5, 2026 and further tranches vest in 2027–2029 (footnote F5).
- ADS note: Ordinary shares may be represented by American Depositary Shares (each currently equals one ordinary share) (footnote F1).
- Shares owned after the transaction: not specified in the provided excerpt of the filing.
Context
- The M (exercise/conversion) entries reflect RSUs vesting and converting into ordinary shares rather than an option purchase. The $0 proceeds line and the footnote indicate shares were withheld or net‑settled to cover tax withholding — a routine administrative step that doesn’t necessarily signal a view on company prospects.
- The open‑market sale generated a modest amount (~$35.7k); sales to cover taxes or required withholding are common after RSU vesting and are generally considered routine rather than a strong negative signal.
Insider Transaction Report
Form 4
Savage Brian
Interim Chief Legal Officer
Transactions
- Exercise/Conversion
Ordinary Shares
[F1][F2]2026-03-05+3,580→ 12,041 total - Sale
Ordinary Shares
[F1][F3][F4]2026-03-05$31.67/sh−1,127$35,690→ 10,914 total - Exercise/Conversion
Restricted Share Units
[F2][F5][F1]2026-03-05−3,580→ 10,740 total→ Ordinary Shares (3,580 underlying)
Footnotes (5)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.26 to $32.34, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]Restricted share units were granted on March 5, 2025, with 3,580 vested on March 5, 2026, and 3,580 vesting on each of March 5, 2027, March 7, 2028 and March 5, 2029.
Signature
/s/ Dov Bergwerk as attorney-in-fact for Brian P. Savage|2026-03-09